Petar Vazharov, Executive Vice President at Alvogen in the CEE region, commented: We are delighted about the start of InflectraTM. This product represents a significant milestone for our biosimilar portfolio, which includes been making great progress since its launch in partnership with Hospira in 2011. Biosimilars provide a huge chance of our business in Eastern European countries and with InflectraTM we demonstrate the continuing growth we are achieving in this essential portfolio. InflectraTM offers a far more inexpensive – but effective – treatment option for victims of inflammatory conditions similarly, offering compelling price saving opportunities within the European Union. Dr. Stan Bukofzer, Corporate Vice President and Chief Medical Officer of Hospira added: The rigorous scientific review carried out by the European Medicines Agency and acceptance by the European Commission confirms that InflectraTM provides demonstrated similar quality, security and efficacy to RemicadeTM.All rights reserved.. Chinese health deteriorating as Western foods become more prominent A recent study within the journal Circulation showed that Chinese men and women who ate Western fast food raised their threat of developing type 2 diabetes and heart disease. Consider the rapid expansion of junk food giants like McDonald’s, Burger King, and Subway in China, and you are placing factors up for disaster. Since 2005, there has been a five-fold increase in obesity compared to 2011. Today, based on the World Health Business, there are more than 38 % of Chinese over the age of 15 that are overweight. On the same note, demand for meats has increased exponentially, increasing over 400 % from the first 1990’s through 2007. Today, more than half of the world’s pigs are consumed in China. Due to China’s booming population, junk food giants have discovered it lucrative to be prominent on the market there extremely.

Other entries from category "nephrology":

Random entries